Elena Campione
Overview
Explore the profile of Elena Campione including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
217
Citations
1566
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Belardi R, Pacifici F, Baldetti M, Velocci S, Minieri M, Pieri M, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076585
Kidney transplantation is currently the treatment of choice for patients with end-stage kidney diseases. Although significant advancements in kidney transplantation have been achieved over the past decades, the host's immune...
2.
Cosio T, Romeo A, Pistoia E, Pica F, Freni C, Iacovelli F, et al.
Microorganisms
. 2025 Feb;
13(2).
PMID: 40005604
() is the most common pathogen responsible for a wide spectrum of human infections ranging from superficial mucocutaneous mycoses to systemic life-threatening diseases. Its main virulence factors are the morphological...
3.
Orsini D, Graceffa D, Burlando M, Campanati A, Campione E, Guarneri C, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004618
: Brodalumab is a monoclonal antibody against the anti-IL-17 receptor A, approved for patients with moderate-to-severe psoriasis. This retrospective study investigated patients in clinical practice to assess the impact of...
4.
Cosio T, Valsecchi I, Gaziano R, Campione E, Botterel F
J Fungi (Basel)
. 2025 Jan;
11(1).
PMID: 39852465
We read the review by Gupta et al [...].
5.
Belardi R, Pacifici F, Cosio T, Lambiase S, Shumak R, Artosi F, et al.
Biomolecules
. 2025 Jan;
14(12.
PMID: 39766219
Actinic keratosis (AK) is a precursor to invasive squamous cell carcinoma, making early diagnosis and treatment essential to prevent progression. Among available therapeutic options, nicotinamide (NAM) has shown potential in...
6.
Campione E, Cosio T, Pistoia E, Artosi F, Shumack R, Borselli C, et al.
Front Immunol
. 2024 Dec;
15:1508489.
PMID: 39720714
Introduction: Fungi, including , may be a trigger or exacerbate psoriasis, especially in difficult to treat (DTT) areas, through the activation of IL-17/23 axis. Methods: In this study, seventy patients...
7.
Cosio T, Shumak R, Borselli C, Artosi F, Gaziano R, Campione E
Med Mycol Case Rep
. 2024 Dec;
46:100683.
PMID: 39634792
Psoriasis is a multifactorial immune-mediated disorder linked to the interleukin (IL)-17 signalling pathway. We present an unusual case of and caused by that developed after starting the IL-17A/F inhibitor bimekizumab....
8.
Campione E, Artosi F, Shumak R, Giunta A, Argenziano G, Assorgi C, et al.
Pharmaceuticals (Basel)
. 2024 Oct;
17(10).
PMID: 39459016
(1) Background/Objectives: Nail psoriasis (NP) is a chronic and difficult-to-treat disease, which causes significant social stigma and impairs the patients' quality of life. Moreover, nail psoriasis is a true therapeutic...
9.
Licata G, Tancredi V, Giuffrida G, Bernardini N, Zichichi L, Campione E
J Clin Aesthet Dermatol
. 2024 Oct;
17(10):18.
PMID: 39445327
No abstract available.
10.
Matteini E, Diluvio L, Lambiase S, Cioni A, Shumak R, Costanza G, et al.
Clin Cosmet Investig Dermatol
. 2024 Oct;
17:2225-2230.
PMID: 39387062
Alopecia areata represents an autoimmune disease that specifically damages growing hair follicles on the scalp and/or around the body. Janus kinase inhibitors have been identified as an effective therapy in...